The global market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

PRRS, also known as Porcine Reproductive and Respiratory Syndrome, is a viral disease that occurs worldwide in all age groups. PRRD has two symptoms: reproductive failure or failure in breeding animals, and respiratory disease in pigs of any age.

Rising awareness about PRRS is driving the growth of the market. Another opportunity for the market includes increasing animal care spending and R&D activities in the veterinary biologics segment. Vaccinated pigs are expected to significantly reduce the frequency of wild-type virus transmission, helping to prevent dangerous diseases. Additionally, rising government investment is also expected to boost global demand for veterinary autologous vaccines during the forecast period. However, R&D costs may hinder the growth of the market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.

The PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Report

Report Metric	Details
Report Name	PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market
Segment by Type	CH-1R Strain PC Strain Others
Segment by Application	Gilts Sows
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, HIPRA, Sinopharm Animal Health Co., Ltd, Ceva Santé Animale, CAVAC, Bioveta, Jinyu Bio-Technology, Zoetis, Boehringer Ingelheim, Harbin Pharmaceutical Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market report?

Ans: The main players in the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market are Merck, HIPRA, Sinopharm Animal Health Co., Ltd, Ceva Santé Animale, CAVAC, Bioveta, Jinyu Bio-Technology, Zoetis, Boehringer Ingelheim, Harbin Pharmaceutical Group

What are the Application segmentation covered in the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market report?

Ans: The Applications covered in the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market report are Gilts, Sows

What are the Type segmentation covered in the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market report?

Ans: The Types covered in the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market report are CH-1R Strain, PC Strain, Others

1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Overview

1.1 Product Definition

1.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Type

1.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 CH-1R Strain

1.2.3 PC Strain

1.2.4 Others

1.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Application

1.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Gilts

1.3.3 Sows

1.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Estimates and Forecasts

1.4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue 2020-2031

1.4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales 2020-2031

1.4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competition by Manufacturers

2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Product Type & Application

2.7 Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Date of Enter into This Industry

2.8 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competitive Situation and Trends

2.8.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Market Share by Revenue

2.8.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Scenario by Region

3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2020-2031

3.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2020-2025

3.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2026-2031

3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2020-2031

3.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2020-2025

3.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2026-2031

3.4 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country

3.4.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2020-2031)

3.4.3 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country

3.5.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2020-2031)

3.5.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country

3.7.1 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2020-2031)

3.7.3 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2020-2031)

4.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2020-2025)

4.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2026-2031)

4.1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2020-2031)

4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2020-2031)

4.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2020-2025)

4.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2026-2031)

4.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2020-2031)

5.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2020-2025)

5.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2026-2031)

5.1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2020-2031)

5.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2020-2031)

5.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2020-2025)

5.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2026-2031)

5.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Company Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 HIPRA

6.2.1 HIPRA Company Information

6.2.2 HIPRA Description and Business Overview

6.2.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio

6.2.5 HIPRA Recent Developments/Updates

6.3 Sinopharm Animal Health Co., Ltd

6.3.1 Sinopharm Animal Health Co., Ltd Company Information

6.3.2 Sinopharm Animal Health Co., Ltd Description and Business Overview

6.3.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio

6.3.5 Sinopharm Animal Health Co., Ltd Recent Developments/Updates

6.4 Ceva Santé Animale

6.4.1 Ceva Santé Animale Company Information

6.4.2 Ceva Santé Animale Description and Business Overview

6.4.3 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio

6.4.5 Ceva Santé Animale Recent Developments/Updates

6.5 CAVAC

6.5.1 CAVAC Company Information

6.5.2 CAVAC Description and Business Overview

6.5.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio

6.5.5 CAVAC Recent Developments/Updates

6.6 Bioveta

6.6.1 Bioveta Company Information

6.6.2 Bioveta Description and Business Overview

6.6.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio

6.6.5 Bioveta Recent Developments/Updates

6.7 Jinyu Bio-Technology

6.7.1 Jinyu Bio-Technology Company Information

6.7.2 Jinyu Bio-Technology Description and Business Overview

6.7.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio

6.7.5 Jinyu Bio-Technology Recent Developments/Updates

6.8 Zoetis

6.8.1 Zoetis Company Information

6.8.2 Zoetis Description and Business Overview

6.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio

6.8.5 Zoetis Recent Developments/Updates

6.9 Boehringer Ingelheim

6.9.1 Boehringer Ingelheim Company Information

6.9.2 Boehringer Ingelheim Description and Business Overview

6.9.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio

6.9.5 Boehringer Ingelheim Recent Developments/Updates

6.10 Harbin Pharmaceutical Group

6.10.1 Harbin Pharmaceutical Group Company Information

6.10.2 Harbin Pharmaceutical Group Description and Business Overview

6.10.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio

6.10.5 Harbin Pharmaceutical Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Chain Analysis

7.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process Analysis

7.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Marketing

7.4.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Channels

7.4.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors

7.5 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customer Analysis

8 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Dynamics

8.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends

8.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers

8.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Challenges

8.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Harbin Pharmaceutical Group

Sinopharm Animal Health Co., Ltd

List of Tables

Table 1. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2020-2025) & (K Units)

Table 18. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2026-2031) & (K Units)

Table 20. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2020-2025) & (K Units)

Table 27. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2026-2031) & (K Units)

Table 28. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2020-2025) & (K Units)

Table 32. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2026-2031) & (K Units)

Table 33. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) by Type (2020-2025)

Table 51. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) by Type (2026-2031)

Table 52. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Type (2020-2025)

Table 59. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Type (2026-2031)

Table 60. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) by Application (2020-2025)

Table 61. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) by Application (2026-2031)

Table 62. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Application (2020-2025)

Table 69. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Application (2026-2031)

Table 70. Merck Company Information

Table 71. Merck Description and Business Overview

Table 72. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product

Table 74. Merck Recent Developments/Updates

Table 75. HIPRA Company Information

Table 76. HIPRA Description and Business Overview

Table 77. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product

Table 79. HIPRA Recent Developments/Updates

Table 80. Sinopharm Animal Health Co., Ltd Company Information

Table 81. Sinopharm Animal Health Co., Ltd Description and Business Overview

Table 82. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product

Table 84. Sinopharm Animal Health Co., Ltd Recent Developments/Updates

Table 85. Ceva Santé Animale Company Information

Table 86. Ceva Santé Animale Description and Business Overview

Table 87. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product

Table 89. Ceva Santé Animale Recent Developments/Updates

Table 90. CAVAC Company Information

Table 91. CAVAC Description and Business Overview

Table 92. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product

Table 94. CAVAC Recent Developments/Updates

Table 95. Bioveta Company Information

Table 96. Bioveta Description and Business Overview

Table 97. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product

Table 99. Bioveta Recent Developments/Updates

Table 100. Jinyu Bio-Technology Company Information

Table 101. Jinyu Bio-Technology Description and Business Overview

Table 102. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product

Table 104. Jinyu Bio-Technology Recent Developments/Updates

Table 105. Zoetis Company Information

Table 106. Zoetis Description and Business Overview

Table 107. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product

Table 109. Zoetis Recent Developments/Updates

Table 110. Boehringer Ingelheim Company Information

Table 111. Boehringer Ingelheim Description and Business Overview

Table 112. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product

Table 114. Boehringer Ingelheim Recent Developments/Updates

Table 115. Harbin Pharmaceutical Group Company Information

Table 116. Harbin Pharmaceutical Group Description and Business Overview

Table 117. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product

Table 119. Harbin Pharmaceutical Group Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors List

Table 123. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers List

Table 124. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Trends

Table 125. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers

Table 126. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Challenges

Table 127. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine

Figure 2. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Type: 2024 & 2031

Figure 4. CH-1R Strain Product Picture

Figure 5. PC Strain Product Picture

Figure 6. Others Product Picture

Figure 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Application: 2024 & 2031

Figure 9. Gilts

Figure 10. Sows

Figure 11. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size (2020-2031) & (US$ Million)

Figure 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2020-2031) & (K Units)

Figure 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price (US$/Unit) & (2020-2031)

Figure 15. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Report Years Considered

Figure 16. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Manufacturers in 2024

Figure 17. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players: Market Share by Revenue in PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in 2024

Figure 19. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2020-2031)

Figure 22. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2020-2031)

Figure 23. United States PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2020-2031)

Figure 26. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2020-2031)

Figure 27. Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2020-2031)

Figure 34. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2020-2031)

Figure 44. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2020-2031)

Figure 45. Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2020-2031)

Figure 50. Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Type (2020-2031)

Figure 54. Global Revenue Market Share of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Type (2020-2031)

Figure 55. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Application (2020-2031)

Figure 57. Global Revenue Market Share of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Application (2020-2031)

Figure 58. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Application (2020-2031)

Figure 59. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions